Sakatani M |
[Multi-drug resistant mycobacterial infection]. |
1999 |
Ryoikibetsu Shokogun Shirizu |
pmid:10088372
|
Wreiber K et al. |
[Development of resistant Helicobacter pylori in Sweden. Tendency toward increasing resistance to clarithromycin]. |
1999 |
Lakartidningen |
pmid:10087796
|
Unge P |
Antibiotic treatment of Helicobacter pylori infection. |
1999 |
Curr. Top. Microbiol. Immunol. |
pmid:10087665
|
Moreau P et al. |
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM) |
1999 |
Leukemia |
pmid:10086745
|
Woo MS et al. |
Pediatric transplant grand rounds. A case presentation: skin lesions in a post-lung transplant patient. |
1997 |
Pediatr Transplant |
pmid:10084776
|
de Jong JJ et al. |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient. |
1999 |
Transpl. Int. |
pmid:10080410
|
Periti P and Mazzei T |
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. |
1999 |
J Chemother |
pmid:10078776
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Marais A et al. |
Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. |
1999 |
Gut |
pmid:10075951
|
Owen RJ |
Helicobacter pylori resists arrest. |
1999 |
Gut |
pmid:10075942
|
Yajima T et al. |
Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. |
1999 |
Chem. Pharm. Bull. |
pmid:10071855
|
Dehesa M et al. |
[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. |
1998 Apr-Jun |
Rev Gastroenterol Mex |
pmid:10068730
|
Vásconez C et al. |
Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. |
1999 |
J. Hepatol. |
pmid:10068106
|
Schultz-Süchting F et al. |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy. |
1999 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10067743
|
Sato K and Tomioka H |
[In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo]. |
1999 |
Kekkaku |
pmid:10067057
|
Nilsson F and Walder M |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance]. |
1999 |
Lakartidningen |
pmid:10064930
|
Keto Y et al. |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin. |
1999 |
Dig. Dis. Sci. |
pmid:10063909
|
Yan JJ et al. |
Disseminated Mycobacterium genavense infection in a patient with acquired immunodeficiency syndrome: first case report in Taiwan. |
1999 |
J. Formos. Med. Assoc. |
pmid:10063276
|
Kistler A et al. |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10052525
|
Woo PC et al. |
Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. |
1999 |
Pharmacol. Res. |
pmid:10051377
|
Wang G et al. |
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10049289
|
Goto T et al. |
[Erosive duodenitis after eradication therapy for Helicobacter pylori]. |
1999 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:10047687
|
Kihira K et al. |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. |
1999 |
Nippon Rinsho |
pmid:10036953
|
Nakagawa M et al. |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036952
|
Shirai T et al. |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036951
|
Habu Y et al. |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease]. |
1999 |
Nippon Rinsho |
pmid:10036950
|
Iwasaki A |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy]. |
1999 |
Nippon Rinsho |
pmid:10036949
|
Sekine H et al. |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment]. |
1999 |
Nippon Rinsho |
pmid:10036947
|
Maeda S and Yoshida H |
[Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability]. |
1999 |
Nippon Rinsho |
pmid:10036941
|
Murakami K and Kimoto M |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan]. |
1999 |
Nippon Rinsho |
pmid:10036940
|
Fukazawa K et al. |
[Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test]. |
1999 |
Nippon Rinsho |
pmid:10036939
|
Sakurai K et al. |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori]. |
1999 |
Nippon Rinsho |
pmid:10036938
|
Horgen L et al. |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium. |
1999 |
FEMS Immunol. Med. Microbiol. |
pmid:10030545
|
Goh KL et al. |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10029275
|
Dubé MP et al. |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. |
1999 |
Clin. Infect. Dis. |
pmid:10028084
|
|
|
|
|
pmid:
|